Immunologic Diagnosis of Active Tuberculosis

참고문헌 (9)

1. Mazurek GH, "IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis Infection - United States 2010", MMWR Recomm Rep, 2010, pp.1~25 (2010)
2. Horsburgh CR Jr, "Latent tuberculosis infection in the United States", N Engl J Med, 364, pp.1441~1448 (2011)
3. Clark SA, "Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease", Clin Exp Immunol, 150, pp.238~244 (2007)
4. Aichelburg MC, "Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals", Clin Infect Dis, 48, pp.954~962 (2009)
5. Kik SV, "Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts", Eur Respir J, 35, pp.1346~1353 (2010)
6. Diel R, "Negative and positive predictive value of a whole-blood interferon- γ release assay for developing active tuberculosis: an update", Am J Respir Crit Care Med, 183, pp.88~95 (2011)
7. Pai M, "Systematic review: T-cellbased assays for the diagnosis of latent tuberculosis infection: an update", Ann Intern Med, 149, pp.177~184 (2008)
8. Cho OH, "Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection", J Infect, 63, pp.362~369 (2011)
9. Feng Y, "Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis", PLoS One, 7, pp.e32652~ (2012)